Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA Read More > April 5, 2016
Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents Read More > April 4, 2016
Race-Based Trauma: The Challenge and Promise of MDMA-Assisted Psychotherapy Read More > April 1, 2016
A systematic review of the effects of novel psychoactive substances ‘legal highs’ on people with severe mental illness Read More > April 1, 2016
A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness Read More > April 1, 2016
Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies Read More > March 24, 2016
Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide Read More > March 24, 2016
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Read More > March 18, 2016
